Atlas Trials

Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria

Clinical trial NCT04061200 · UNKNOWN

Trial details

NCT number
NCT04061200
Sponsor
Steno Diabetes Center Copenhagen
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes With Renal Manifestations
Start date
2019-11-01
Primary completion
2021-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.